Henry Ford Cancer Institute treats its first patient with innovative 'living drug' therapy

(Henry Ford Health System) Henry Ford Cancer Institute has treated its first patient with CAR T-cell therapy, an approach that uses engineered cells from a patient's immune system to destroy cancer. The altered cells remain active for years after the treatment, acting as a 'living drug.'